SCHEMBL17810060

SCHEMBL17810060

Brc1ccc2c(c1)c1cccc3c1n2-c1ccccc1-c1ccccc1-3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38
IDO2 Q6ZQW0 1/20 0.38
TSPO P30536 2/20 0.37
DNMT1 P26358 1/20 0.36
DUSP3 P51452 1/20 0.36
PTPRC P08575 1/20 0.35
GSK3B P49841 5/20 0.34
CCNB2 O95067 4/20 0.34
CDK1 P06493 4/20 0.34
CCNB1 P14635 4/20 0.34
CCNB3 Q8WWL7 4/20 0.34
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.33
RAD52 P43351 1/20 0.33
KMT2A Q03164 1/20 0.33
PDE4B Q07343 1/20 0.33
DNM1 Q05193 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HKDC1 Q2TB90 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17810062 0.88 PTPRC (0.39) IDO1TDO2IDO2TSPODNMT1
SCHEMBL17810053 0.88 IDO1 (0.44) IDO1TDO2IDO2TSPODUSP3
SCHEMBL1832121 0.87 DNMT1 (0.41) IDO1TDO2IDO2TSPODNMT1
SCHEMBL17809860 0.84 DUSP3 (0.38) IDO1TDO2IDO2TSPODNMT1
SCHEMBL26529649 0.83 POLB (0.38) IDO1TDO2IDO2TSPODNMT1
SCHEMBL17809832 0.81 DUSP3 (0.50) IDO1TDO2IDO2DNMT1DUSP3
SCHEMBL17810074 0.81 ALDH1A1 (0.43) DUSP3PTPRCMAPTMEN1KMT2A
SCHEMBL26529663 0.81 DNMT1 (0.39) IDO1TDO2IDO2TSPODNMT1
SCHEMBL24658996 0.81 KDM4E (0.38) IDO1TDO2IDO2DUSP3GSK3B
SCHEMBL25686988 0.79 PDE7A (0.35) IDO1TDO2IDO2TSPODNMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9502667-B2 Organic electroluminescence IDEMITSU KOSAN CO., LTD. (JP) 2016-11-22 US disclosed
US-9502667-B2 Organic electroluminescence IDEMITSU KOSAN CO., LTD. (JP) 2016-11-22 US disclosed
US-20160163998-A1 ORGANIC ELECTROLUMINESCENCE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-09 US disclosed
US-20160163998-A1 ORGANIC ELECTROLUMINESCENCE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160163998-A1 ORGANIC ELECTROLUMINESCENCE EML4, ODC1, NDC1 IDO1 3015/4885TDO2 2619/4885IDO2 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.